Manapol aloe vera gel extract. Manapol extract, Mannatech’s very special polysaccharide, is a long-chain carbohydrate consisting mostly of the simple sugar mannose. It was licensed to Mannatech in 1994 when we first introduced the world’s first glyconutritional product, Man•Aloe® supplement, and it is exclusive to Mannatech today. It was revolutionary then, and it’s revolutionary now.

Video http://www.youtube.com/watch?v=NcKhR7LddN8

What Makes Manapol Extract Revolutionary?

Back in the 1980s, scientists were accustomed to attributing the benefits of foods and medicinal plants to their constituent vitamins, minerals, fats or proteins. Back then, Dr. Bill McAnalley (who later became Mannatech’s first Chief Science Officer) ( youtube video ob Bill McAnalle http://bit.ly/LSsns2)  and other scientists discovered that many of the amazing topical and oral benefits of aloe vera gel could be attributed to a polysaccharide (that Dr. McAnalley isolated in its stabilized [acetylated^‡] form and named Acemannan). Researchers demonstrated that these mannose-rich long chains of sugars in aloe vera gel provided impressive immune system support.* Dr. McAnalley then developed the Manapol extract by modifying Acemannan so that it was suitable for human dietary intake.

Dr. McAnalley soon became interested in the role that mannose plays in human cellular communication, and went on to develop Mannatech’s second and third generation glyconutritional dietary supplements, Ambrotose® complex and Advanced Ambrotose® products. Leading the way as a pioneer in glyconutritional technology, Mannatech remains committed to the science of life-changing wellness possibilities. To date, more than 50 patents related to the technology behind our Ambrotose products have been issued globally, and these products are available exclusively through Mannatech.

More on Manapol Powder

Manapol powder is extracted from fresh, washed and filtered aloe vera gel by a specialized extraction method that yields insoluble fibers and stabilized, high molecular weight (MW) soluble fibers rich in long-chain mannose sugars—β-(1-4)-acetylated polymannans. The MW of over 20% of Manapol is >800,000. It also contains the monosaccharide sugars arabinose, fucose, galactose, galacturonic acid, glucosamine, glucose, glucuronic acid, rhamnose and xylose (1),(2),(3). Ambrotose complex powder provides an excellent source of Manapol powder.

Reference List

1.   Luta G, McAnalley B. Aloe vera: chemical composition and methods used to determine its presence in commercial products. GlycoScience & Nutrition 2005;6:1–12.

2.   Duncan, C., Ramberg, J., and Sinnott, R. Striking  differences in Aloe vera gel carbohydrate composition, molecular weight and particle size distributions following processing will not be addressed by dietary supplement GMPs.  1-5. 2008. Poster Presentation at the Scripps Center for Integrative Medicine’s 5th Annual Natural Supplements Conference, San Diego, California. January 17–20, 2008.

3.   Luta G, Duncan C, Sinnott R. Chemical characterization of polysaccharide-rich ingredients from Aloe vera, Larix laricina and Larix occidentalis, and Undaria pinnatifida. Poster Presentation at the Scripps Center for Integrative Medicine’s 6th Annual Natural Supplements Conference, San Diego, California. January 22–25, 20

This is a new CPR technique which is much simpler with better results than traditional CPR. It is a very important video  regarding the latest CPR procedure. It does NOT require mouth-to-mouth.

Please watch and forward to your friends and family if you haven’t already done so. You never know, a life may be saved utilizing this new procedure.

http://medicine.arizona.edu/spotlight/learn-sarver-heart-centers-continuous-chest-compression-cpr

January 12, 2012 By admin

A patent is a legal form of protection granted to an inventor of a useful product or process, allowing the individual (or company) to retain sole ownership of the thing or the idea, so that others cannot make, use, sell or distribute it without permission. In all countries, patents are valid for a limited number of years (generally about 20 from the filing date in the U.S.), providing the inventor with a reasonable amount of time to share the intellectual property publicly and sell and distribute it exclusively.

Getting a patent is not easy. In fact, the process consists of a rigorous maze of hurdles and qualifications that must be successfully navigated and cleared. After patent applications have been reviewed, thorough examinations have been made (usually by scientists and engineers) and the invention has been exhaustively vetted, then a patent may be granted. At this point, the inventor’s idea, or intellectual property, will be protected under a specific set of guidelines and rules. If a patent is infringed upon, the patentee may sue the unauthorized user/seller in federal court.

So, when a patent is granted, it’s safe to say that it’s serious business and the product or idea is one of great efficacy, value and integrity.

What does this have to do with Mannatech?

Everything.

Patents? Dr. John Rollins Has More Than 70.

Mannatech’s proprietary product, Ambrotose^® , doesn’t just have a patent. It has more than 50 patents in countries all over the world. That is no small feat.

And if that isn’t enough to eliminate any questions about whether Mannatech is a scam, consider Dr. John Rollins, a top-notch medical biologist. For 15 years, he was a Biotech Patent Examiner at the U.S. Office of Trademarks and Patents in Washington, D.C. He not only endorses Mannatech and Ambrotose products, he was also working at the Patent Office when the technology behind Ambrotose was being reviewed.

Dr. Rollins often shares the story of his first encounter with Ambrotose in the 1980s. He was examining a series of patent applications from an inventor, Dr. Bill McAnalley, who claimed he had been able to isolate a particular compound from aloe and that this compound was a saccharide, or complex sugar, that supported the immune system and affected cell-to-cell communication. Dr. Rollins says he was “skeptical” when he first heard about it because, at that time, in the area of glycobiology technologies, sugars didn’t have the reputation for supporting things like the immune system and cell-to-cell communication.

However, as Dr. Rollins began to examine the technology a little more he says, “…it was a goose pimple raising experience for me.”

“We could see that this discovery really was going against the grain of what glycobiologists were thinking. This theory of supporting the immune system, of supporting cell-to-cell communication, was 180 degrees away from the thinking of the traditional carbohydrate chemist . . . now, of course, we understand why a new scientific theory, particularly one as bold and game-changing as this is, received such scrutiny.”

The next time you hear or read about a “scam” related to Mannatech, remember that this company has several proprietary products, and more than 70 patents have been issued worldwide for the technology related to some of those products.  Then think about the highly critical patent review process. If Mannatech did not have viable and innovative technology to offer, it wouldn’t have so many patents.

To learn more about Mannatech’s highly acclaimed Ambrotose products, go to Ambrotose.com today. You’ll see that this product, and Mannatech, is just about as real as it gets.

 

COPPELL, Texas, Dec 01, 2011 (BUSINESS WIRE) — Mannatech, Incorporated MTEX +2.04% , the leading innovator and provider of nutritional supplements and skin care products based on Real Food Technology(R) solutions, is happy to announce that early registration for the “Nutrition and Personal Health Coaching” course designed by the Department of Nutrition and Food Sciences at , with input from Mannatech scientists, is now open at $100 off the regular price until December 30, 2011.

This unique, science-based, online course was designed to meet the growing demand of both health professionals and members of the general public who are eager to learn more about health and nutrition and discover how to implement this knowledge in realistic ways into their daily lives. With this curriculum, individuals can bolster their wellness business and/or overall knowledge about nutrition, integrative health, supplements and achieving a healthier lifestyle.

The highly qualified members of the TWU faculty bring a diverse array of training and nutrition-based backgrounds to the program. Dr. Chandan Prasad, Professor and Chairman of the Department of Nutrition and Food Sciences at TWU, spent several years at the National Institutes of Health, was a Professor and Vice Chairman in the Department of Medicine at Louisiana State University, has authored/co-authored more than 200 papers in the area of nutrition, and holds three U.S. and international patents. Dr. Prasad is one of the many distinguished faculty members who will teach this exciting, informative course.

This innovative TWU course also includes a guest lecture from Dr. Rob Sinnott, Co-CEO and Chief Science Officer at Mannatech, about the Dietary Supplement Health and Education Act of 1994 (DSHEA). Upon completion of this 45-hour, university-level program, participants will earn a Certificate of Completion of Training as well as continuing education credit hours.

Most courses with this kind of academic pedigree cost around $1,500 or more. TWU is offering this extensive training for $525. But the preregistration cost, beginning December 1, 2011, is only $425. More information about this course can be found on the TWU website.

Individuals interested in Mannatech’s products or exploring its business opportunity are encouraged to learn more at Mannatech.com.

Mannatech, Incorporated, develops high-quality health, weight and fitness, and skin care products that are based on the solid foundation of nutritional science and development standards. Mannatech is dedicated to its platform of Social Entrepreneurship based on the foundation of promoting, aiding and optimizing nutrition where it is needed most around the world. Mannatech’s proprietary products are available through independent sales Associates around the globe including the United States, Canada, South Africa, Australia, New Zealand, Austria, Denmark, Germany, Norway, Sweden, the Netherlands, the United Kingdom, Japan, Taiwan, Singapore, Estonia, Finland, the Republic of Ireland, Czech Republic, the Republic of Korea and Mexico. For more information, visit Mannatech.com.

Please note: This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as “intend” or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech’s objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties and other factors. Some of these factors include, among others, Mannatech’s inability to attract and retain Associates and Members, increases in competition, litigation, regulatory changes and its planned growth into new international markets. Although Mannatech believes that the expectations, statements and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.

Music Therapy: Natural, No Side Effects And Free

It’s always nice when a scientific study proves what most of us already know: A cancer treatment doesn’t have to involve drugs and a hospital to be effective. And sometimes a good treatment is even FREE.

New research shows music therapy is clearly effective. A scientific review published in August in The Cochrane Reviews shows music can reduce anxiety and pain for cancer patients. That’s because cancer is more than just a physical problem. It also brings emotional pain.

The review included 30 separate studies of more than 1,800 participants who experienced “music intervention.” Music was used as a complementary therapy for patients who underwent standard clinical treatments like radiation, chemotherapy and, in some cases, surgery.

One of the most interesting things about this review was that it considered the patients’ music preferences. Patients weren’t asked to listen to standard-order classical music or soothing nature sounds. They chose their own tunes. This meant even heavy metal and hip-hop made the cut in terms of sounds that provide benefits.

Whatever Floats Your Boat

The study indicates that the style of music used doesn’t seem to matter in music therapy — you should go with your own preferences. My gut feeling is that there’s a flaw in this idea, but the researchers found any kind of music can do the job.

But it could be true to this extent: Music therapy doesn’t just soothe. It’s not all about relaxation. It’s also a way to cope with anxiety about your next hospital visit or treatment session. There are other benefits, too, including small improvements in heart rate, respiratory rate and blood pressure.

Of course, the researchers were quick to note the potential for bias in something so subjective. All the same, plenty of studies show music activates the same pleasure centers in the brain as food and sex. Music makes you feel better.

There’s hardly anything bad you can say about music therapy, especially if you’re looking at it as a way to improve conventional treatments like chemotherapy. Music involves very little cost and has virtually no side effects. http://tinyurl.com/chor99e

If it brings the patient renewed hope and rejuvenation, as these studies say, then it certainly won’t hurt and likely helps. Sounds like a good idea to me.

In other cancer good news, researchers are getting a new view of prostate cancer. Overtreatment is a big concern in prostate cancer. It can result in serious side effects that last a lifetime, including impotence and incontinence. At least, that’s true of surgery and radiation — the most commonly used therapies for prostate cancer.

That makes it especially interesting to learn that researchers in Sweden and Seattle have identified genetic markers to help pinpoint men with the most aggressive form of prostate cancer.

Most prostate cancer is not aggressive. It’s best left alone. But a small number of prostate tumors — supposedly about 10 percent — grow like crazy and kill fast. That’s what makes so many men and nearly all cancer doctors so willing to hack and burn without pausing to ask if the cancer is aggressive or not.

A test to identify which prostate cancers are aggressive would, thus, be a huge step forward. Recent discoveries offer hope.

The newly identified markers are gene variants known as single-nucleotide polymorphisms (SNPs), which are gaining ground as indicators for disease progression. In the study, DNA samples from more than 4,000 prostate cancer patients were analyzed for gene variants. Twenty-two SNPs were linked to prostate cancer-specific death; five of those showed significant association.

This discovery could translate to a basic blood test that separates those who need aggressive treatment from those who have non-aggressive prostate cancers.

Prostate cancer kills 30,000 men each year. Roughly 200,000 prostate cancers are diagnosed annually. It tends to be slow-growing, and most men diagnosed are likely to die of other causes before the cancer turns deadly. Still, most prostate cancer patients tend to be treated with radiation or surgery, since there’s no reliable way to figure out whether their cancers are aggressive. At least, that’s been the case until now.

The next step for the researchers involved in this study is to confirm their findings on different groups of patients; let’s hope their results are as promising as this preliminary research.

Dogs Recognize Cancer

On another cancer front, research confirms that dogs can smell cancer. This startling news recently surfaced from Germany. Researchers there tested whether dogs could tell the difference between test tubes with breath samples of cancer patients versus those without cancer.

The dogs, which were trained to lie down in front of the test tubes where they smelled cancer and touch the vials with their noses, had a surprising 71 percent success rate.

Dogs have actually been able to sniff out several forms of the disease, including breast cancer, bowel cancer and colon cancer. An early theory is that cancer cells produce chemical compounds which circulate throughout the body. These same compounds can exit the body in gaseous form via the lungs, affecting the breath of those with the disease.

Scientists aren’t sure exactly how to use dogs as cancer-detection aids, but current thinking points to some kind of early detection process. These findings at least clue us in to the fact that there must be compounds in the breath of patients with cancer. Hopefully, this will be translated into some kind of early warning sign for those likely to develop cancer.

The next step is figuring out what those compounds are. For now, it’s not necessarily useful information, but it sure is interesting.

Lee Euler He’s written about alternative health for 18 years, and his books and articles have been read by millions. He’s written for publications edited by Dr. David Williams, Dr. Julian Whitaker, Dr. William Campbell Douglass, Dr. Mark Stengler, Health Sciences Institute and others. You can visit his website at www.cancerdefeatedpublications.com.

*********************

 

November 29, 2011 by Easy Health Options Staff